Efficacy of SGLT2i + DPP4i FDCs Evidence from numerous clinical trials suggest that SGLT2i + DPP4i FDCs are effective and safe in controlling glycemic parameters in patients with T2DM
As interest in GLP-1 therapy continues to grow, many conversations focus less on the medications themselves and more on everyday realities such as GLP-1 cost, GLP-1 side effects, and GLP-1 accessibility
The catch is that breastfeeding can increase appetite to compensate for the caloric expenditure
Drink it alongside, not instead of, water
Thats why I went to Trustpilot, where over 6,000 patients have left reviews
In a Phase 2 trial for T2D, weekly semaglutide was more effective at reducing HbA1c than daily liraglutide (NCT00696657)